ANIP
Price:
$54.07
Market Cap:
$1.14B
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-05-05
Stock Exchange
NASDAQ
Ticker
ANIP
According to ANI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.62B. This represents a change of 18.58% compared to the average of 1.36B of the last 4 quarters.
The mean historical Enterprise Value of ANI Pharmaceuticals, Inc. over the last ten years is 749.37M. The current 1.62B Enterprise Value has changed 21.48% with respect to the historical average. Over the past ten years (40 quarters), ANIP's Enterprise Value was at its highest in in the September 2024 quarter at 1.64B. The Enterprise Value was at its lowest in in the September 2015 quarter at 414.06M.
Average
749.37M
Median
777.28M
Minimum
471.81M
Maximum
1.06B
Discovering the peaks and valleys of ANI Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 515.75%
Maximum Annual Enterprise Value = 1.06B
Minimum Annual Increase = -38.47%
Minimum Annual Enterprise Value = 471.81M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.06B | 18.45% |
2022 | 892.43M | 16.28% |
2021 | 767.49M | 46.12% |
2020 | 525.26M | -38.47% |
2019 | 853.65M | 28.23% |
2018 | 665.71M | -27.21% |
2017 | 914.57M | 16.20% |
2016 | 787.07M | 66.82% |
2015 | 471.81M | -15.54% |
2014 | 558.62M | 515.75% |
The current Enterprise Value of ANI Pharmaceuticals, Inc. (ANIP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
905.68M
5-year avg
819.19M
10-year avg
749.37M
ANI Pharmaceuticals, Inc.’s Enterprise Value is greater than Eagle Pharmaceuticals, Inc. (19.21M), greater than Phibro Animal Health Corporation (1.10B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (4.89B), less than Alkermes plc (4.75B), less than Dr. Reddy's Laboratories Limited (1.16T), less than Collegium Pharmaceutical, Inc. (1.78B), greater than Pacira BioSciences, Inc. (1.29B), greater than Procaps Group S.A. (552.38M), greater than Silver Spike Investment Corp. (0), less than Neurocrine Biosciences, Inc. (13.77B), less than Amphastar Pharmaceuticals, Inc. (2.27B), greater than Ironwood Pharmaceuticals, Inc. (1.27B), greater than InterCure Ltd. (423.49M),
Company | Enterprise Value | Market cap |
---|---|---|
19.21M | $6.74M | |
1.10B | $863.54M | |
2.15B | $2.21B | |
4.89B | $3.88B | |
4.75B | $4.78B | |
1.16T | $13.02B | |
1.78B | $940.25M | |
1.29B | $889.06M | |
552.38M | $280.02M | |
0 | $66.72M | |
13.77B | $13.87B | |
2.27B | $1.83B | |
1.27B | $741.73M | |
423.49M | $79.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ANI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ANI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ANI Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ANI Pharmaceuticals, Inc. (ANIP)?
What is the 3-year average Enterprise Value for ANI Pharmaceuticals, Inc. (ANIP)?
What is the 5-year average Enterprise Value for ANI Pharmaceuticals, Inc. (ANIP)?
How does the current Enterprise Value for ANI Pharmaceuticals, Inc. (ANIP) compare to its historical average?